Skip to the page

Data / Form D filings / Talus Bioscience, Inc.

Talus Bioscience, Inc.: Form D filing

Talus Bioscience, Inc., a technology company in Seattle, WA, filed a Form D with the SEC in 2024. The latest, on August 12, 2024, reports $9.4 million sold of a $11.3 million offering to 11 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
550 17th Avenue, Suite 550, Seattle, WA, 98122
Phone
(206) 487-1062
Industry
Other Technology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2020
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2033246

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Aug 12, 2024New notice$11,300,000$9,423,516$1,876,48411Jul 29, 2024sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Lindsay PinoExecutive Officer, Director
Michelle BriscoeExecutive Officer
Alex FederationExecutive Officer, Director, Promoter
Omri Amirav-DroryDirector
J. Seth StrattanDirector

Other technology companies in Washington that filed recently

Every Form D from the week of Aug 12, 2024 · All recent filings in Washington · All recent Other Technology filings

Read from SEC EDGAR. Amount sold is what Talus Bioscience, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.